Correlation of laterally spreading type and JC virus with methylator phenotype status in colorectal adenoma

Human Pathology

Volumn 39, Issue 5, 2008, Pages 767-775

  Nosho, Katsuhiko ^a   Yamamoto, Hiroyuki ^a   Takahashi, Taiga ^a   Mikami, Masashi ^a   Hizaki, Keiichi ^a   Maehata, Tadateru ^b   Taniguchi, Hiroaki ^a   Yamaoka, Satoshi ^a   Adachi, Yasushi ^a   Itoh, Fumio ^b   Imai, Kohzoh ^c   Shinomura, Yasuhisa ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

BRAF; CIMP; Colorectal adenoma; JC virus; LST

Indexed keywords

B RAF KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; K RAS PROTEIN; NEUROGENIN 1; PROTEIN MLH1; VIRUS T ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JC VIRUS; MAJOR CLINICAL STUDY; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOMA; AGED; ANTIGENS, VIRAL, TUMOR; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CALCIUM CHANNELS, T-TYPE; COLORECTAL NEOPLASMS; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JC VIRUS; MALE; METHYLATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; RECEPTORS, RETINOIC ACID;

EID: 42649086015     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.10.005     Document Type: Article

References (35)

1. Kudo S. Endoscopic mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy 25 (1993) 455-461
2. Kusaka T., Fukui H., Sano Y., et al. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors. J Gastroenterol Hepatol 15 (2001) 1151-1157
3. Noro A., Sugai T., and Habano W. Analysis of Ki-ras and p53 gene mutations in laterally spreading tumors of the colorectum. Pathol Int 53 (2003) 828-836
4. Hurlstone D.P., Sanders D.S., Cross S.S., et al. Colonoscopic resection of lateral spreading tumours: a prospective analysis of endoscopic mucosal resection. Gut 53 (2004) 1334-1339
5. Mukawa K., Fujii S., Takeda J., et al. Analysis of K-ras mutations and expression of cyclooxygenase-2 and gastrin protein in laterally spreading tumors. J Gastroentrol Hepatol 20 (2005) 1584-1590
6. Nosho K., Yamamoto H., Mikami M., et al. Laterally spreading tumour in which interstitial deletion of beta-catenin exon 3 was detected. Gut 54 (2005) 1504-1505
7. Uraoka T., Saito Y., Matsuda T., et al. Endoscopic indications for endoscopic mucosal resection of laterally spreading tumours in the colorectum. Gut 55 (2006) 1592-1597
8. Hiraoka S., Kato J., Tatsukawa M., et al. Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras mutations. Gastroenterology 131 (2006) 379-389
9. Takahashi T., Nosho K., Yamamoto H., et al. Flat-type colorectal advanced adenomas (laterally spreading tumors) have different genetic and epigenetic alterations from protruded-type advanced adenomas. Mod Pathol 20 (2007) 139-147
10. Laird P.W. Cancer epigenetics. Hum Mol Genet 14 (2005) R65-R76
11. Kondo Y., and Issa J.P. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev 23 (2004) 29-39
12. Rashid A., and Issa J.P. CpG island methylation in gastroenterologic neoplasia: a maturing field. Gastroenterology 127 (2004) 1578-1588
13. Issa J.P. CpG island methylator phenotype in cancer. Nat Rev Cancer 4 (2004) 988-993
14. Chan A.O., Issa J.P., Morris J.S., Hamilton S.R., and Rashid A. Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol 160 (2002) 529-536
15. Jass J.R. Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol 2 (2005) 398-405
16. van Rijnsoever M., Grieu F., Elsaleh H., Joseph D., and Iacopetta B. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut 51 (2002) 797-802
17. Toyota M., Ahuja N., Ohe-Toyota M., et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96 (1999) 8681-8686
18. Toyota M., Ohe-Toyota M., Ahuja N., and Issa J.P. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc Natl Acad Sci U S A 97 (2000) 710-715
19. Hawkins N., Norrie M., Cheong K., et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 122 (2002) 1376-1387
20. Samowitz W.S., Albertsen H., Herrick J., et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 129 (2005) 837-845
21. Kambara T., Simms L.A., Whitehall V.L., et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53 (2004) 1137-1144
22. Nagasaka T., Sasamoto H., Notohara K., et al. Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J Clin Oncol 22 (2004) 4584-45894
23. Nosho K., Yamamoto H., Takahashi T., et al. Genetic and epigenetic profiling in early colorectal tumors and prediction of invasive potential in pT1 (early invasive) colorectal cancers. Carcinogenesis 28 (2007) 1364-13670
24. Goel A., Li M.S., Nagasaka T., et al. Association of JC virus T-antigen expression with the methylator phenotype in sporadic colorectal cancers. Gastroenterology 130 (2006) 1950-1961
25. Shin S.K., Li M.S., Fuerst F., et al. Oncogenic T-antigen of JC virus is present frequently in human gastric cancers. Cancer 107 (2006) 481-488
26. Imperiale T.F., Ransohoff D.F., Itzkowitz S.H., Turnbull B.A., Ross M.E., and Colorectal Cancer Study Group. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351 (2004) 2704-2714
27. Morikawa T., Kato J., Yamaji Y., et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 129 (2005) 422-428
28. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc 58 (2003) S3-S43
29. Ogino S., Cantor M., Kawasaki T., et al. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 55 (2006) 1000-1006
30. Ogino S., Kawasaki T., Ogawa A., et al. Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype. Hum Pathol 38 (2007) 842-849
31. Ogino S., Kawasaki T., Ogawa A., et al. TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer. Hum Pathol 38 (2007) 614-620
32. Ogino S., Kawasaki T., Ogawa A., et al. Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype. Hum Pathol 38 (2007) 585-592
33. Ogino S., Kawasaki T., Kirkner G.J., Loda M., and Fuchs C.S. CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J Mol Diagn 8 (2006) 582-588
34. Ogino S., Kawasaki T., Brahmandam M., et al. Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn 8 (2006) 209-217
35. Weisenberger D.J., Siegmund K.D., Campan M., et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38 (2006) 787-793